Cat. No. | Product name | CAS No. |
DCAPI1408 |
Echinocandin B0
Echinocandin B0 |
150283-04-8 |
DCAPI1126 |
Econazole nitrate (Spectazole)
Econazole nitrate (Spectazole) |
24169-02-6 |
DCAPI1380 |
Edaravone (MCI-186)
Edaravone (MCI-186) |
89-25-8 |
DCAPI1479 |
Efavirenz
Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip |
154598-52-4 |
DCAPI1410 |
Eldecalcitol
Featured
Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is an analog of 1,25-dihydroxyvitamin D3 that improves bone mineral density. Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is more efficaci |
104121-92-8 |
DCAPI1504 |
Elocalcitol
Elocalcitol |
199798-84-0 |
DCAPI1196 |
Eltrombopag (SB-497115-GR)
Featured
Eltrombopag (SB-497115-GR) |
496775-61-2 |
DCAPI1334 |
Enalapril maleate (Vasotec)
Enalapril maleate (Vasotec) |
76095-16-4 |
DCAPI1356 |
Epalrestat
Featured
Epalrestat is an orally active aldose reductase inhibitor that acts on diabetic neuropathy. |
82159-09-9 |
DCAPI1014 |
Eplerenone
Featured
Eplerenone, also known as Inspra and CGP-30083, is a selective aldosterone receptor antagonist used to treat hypertension and congestive heart failure. Eplerenone provides marked protection against vascular injury in the kidney and heart. |
107724-20-9 |
DC9171 |
Eprosartan mesylate
Eprosartan is a nonpeptide angiotensin II receptor antagonist with IC50 of 9.2 and 3.9 nM in rat and human adrenal cortical membranes, respectively. |
144143-96-4 |
DCAPI1365 |
Erdosteine
Erdosteine |
84611-23-4 |
DCAPI1539 |
Eribulin Mesylate
Featured
Eribulin is an anticancer drug marketed by Eisai Co. under the trade name Halaven. Eribulin is also known as E7389 and ER-086526, and also carries the US NCI designation NSC-707389. It is used to treat certain patients with breast cancer and liposarcoma. |
441045-17-6 |
DCAPI1516 |
Eribulin
Eribulin Mesylate (E7389 Mesylate), a synthetic analogue of halichondrin B in phase III clinical trials for breast cancer, binds to tubulin and microtubules. |
253128-41-5 |
DCAPI1423 |
Esomeprazole
Esomeprazole |
119141-88-7 |
DCAPI1487 |
Esomeprazole(magnesium)
Esomeprazole(magnesium) |
161973-10-0 |
DCAPI1200 |
Estradiol
Estradiol |
50-28-2 |
DC9016 |
Etamsylate
Ethamsylate is a haemostatic drug, also inhibits biosynthesis and action of those prostaglandins. |
2624-44-4 |
DCAPI1235 |
Ethionamide
Ethionamide |
536-33-4 |
DCAPI1535 |
Etodolac
Etodolac is a Cox-2 inhibitor with anti-inflammatory and analgesic activity. Etodolac is shown to inhibit growth and PCNA expression and induce cell cycle arrest in human hepatocellular carcinoma cell lines, in addition to suppressing the occurrence of ab |
41340-25-4 |
DCAPI1084 |
Ezetimibe (Zetia)
Featured
Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator. |
163222-33-1 |
DCAPI1576 |
Falecalcitriol
Falecalcitriol |
83805-11-2 |